GlassScriptPhysician profile
Sarah D Stowe
NPI 1538891015
$1,864.28
in general payments reported to CMS, 2019-2025
20 companies · $73.72 in 2025
The $73.72 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $262 · 2023: $1,019 · 2024: $509 · 2025: $73.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $269.63 | 2023 | |
| Medtronic, INC. | $181.03 | 2024-2025 | Closurefast |
| Teva Pharmaceuticals USA, INC. | $172.17 | 2022-2023 | Ajovy |
| Astrazeneca Pharmaceuticals LP | $161.45 | 2023-2024 | Tagrisso, Farxiga |
| Beigene USA, INC. | $149.99 | 2024 | Brukinsa |
| Mayne Pharma Commercial LLC | $129.91 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $121.07 | 2024 | Rexulti |
| Exact Sciences Corporation | $110.50 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $101.81 | 2022-2023 | Mounjaro, Emgality |
| Novo Nordisk INC | $86.39 | 2023 | Wegovy, Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $86.36 | 2022-2023 | Trintellix |
| Amgen INC. | $62.73 | 2022-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $53.06 | 2023 | M-M-R II, Varivax, Vaxelis |
| Biohaven Pharmaceutical Holding Company LTD. | $38.62 | 2022 | |
| Pfizer INC. | $37.14 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $28.52 | 2023 | Azstarys |
| Exeltis, USA INC. | $24.28 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.56 | 2022 | |
| Cranial Technologies, INC | $16.54 | 2023 | Doc Band |
| Lundbeck LLC | $15.52 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Stowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.